Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map
Authors:
- Kenneth BlumKBKenneth Blum
- William B. DownsWDWilliam B. Downs
- Margret A. MadiganMMMargret A. Madigan
- Roger L. WaiteRWRoger L. Waite
- Swetha YeldandiSYSwetha Yeldandi
- Neil MajmundarNMNeil Majmundar
- John GiordanoJGJohn Giordano
- 1 April 2011
- journal article
- research article
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 43 (2) , 108-127
Abstract
This document presents evidence supporting the role of the KB220/KB220Z neuroadaptagens consisting of amino-acid neurotransmitter precursors and enkephalinase-catecholamine–methyl-transferase (COMT) inhibition therapy called Neuroadaptagen Amino Acid Therapy (NAAT) in brain reward function. It is becoming increasingly clear that this novel formulation is the first neuroadaptagen known to activate the brain reward circuitry. Ongoing research repeatedly confirms the numerous clinical effects that ultimately result in significant benefits for victims having genetic antecedents for all addictive, compulsive and impulsive behaviors. These behaviors are correctly classified under the rubric of “Reward Deficiency Syndrome” (RDS). We are proposing a novel addiction candidate gene map. We present preliminary findings in the United States using qEGG and in China using Functional Magnetic Resonance Imaging (fMRI) regarding the effects of oral NAAT on the activation of brain reward circuitry in victims of SUD. In unpublished data utilizing an fMRI 2X2 design at resting state, NAAT in comparison to placebo shows activation of the caudate brain region and potentially a smoothing out of heroin-induced putamen (a site for emotionality) abnormal connectivity. Although awaiting final analysis, if confirmed by ongoing studies in China coupled with published qEEG results in America, showing an increase in alpha and low beta, NAAT may be shown to impact treatment outcomes.Keywords
This publication has 86 references indexed in Scilit:
- Is Slow-Onset Long-Acting Monoamine Transport Blockade to Cocaine as Methadone is to Heroin? Implication for Anti-Addiction MedicationsNeuropsychopharmacology, 2010
- A Critical Evaluation of Influence of Ethanol and Diet on Salsolinol Enantiomers in Humans and RatsAlcohol, Clinical and Experimental Research, 2010
- Addiction related alteration in resting-state brain connectivityNeuroImage, 2010
- Evaluating Dopamine Reward Pathway in ADHDJAMA, 2009
- Haplotypic Variants in DRD2, ANKK1, TTC12, and NCAM1 are Associated With Comorbid Alcohol and Drug DependenceAlcohol, Clinical and Experimental Research, 2008
- Addictions Biology: Haplotype-Based Analysis for 130 Candidate Genes on a Single ArrayAlcohol and Alcoholism, 2008
- D2R DNA transfer into the nucleus accumbens attenuates cocaine self‐administration in ratsSynapse, 2008
- EEG Biofeedback as a Treatment for Substance Use Disorders: Review, Rating of Efficacy, and Recommendations for Further ResearchApplied Psychophysiology and Biofeedback, 2008
- Opioid neuropeptide genotypes in relation to heroin abuse: Dopamine tone contributes to reversed mesolimbic proenkephalin expressionProceedings of the National Academy of Sciences, 2008
- Distinctive Profiles of Gene Expression in the Human Nucleus Accumbens Associated with Cocaine and Heroin AbuseNeuropsychopharmacology, 2006